Phenotypically Adapted Mycobacterium tuberculosis Populations from Sputum Are Tolerant to First-Line Drugs

被引:38
|
作者
Turapov, Obolbek [1 ]
O'Connor, Benjamin D. [1 ]
Sarybaeva, Asel A. [1 ]
Williams, Caroline [1 ]
Patel, Hemu [2 ]
Kadyrov, Abdullaat S. [3 ]
Sarybaev, Akpay S. [4 ]
Woltmann, Gerrit [5 ]
Barer, Michael R. [1 ,2 ]
Mukamolova, Galina V. [1 ]
机构
[1] Univ Leicester, Dept Infect Immun & Inflammat, Leicester, Leics, England
[2] Univ Hosp Leicester NHS Trust, Dept Clin Microbiol, Empath Pathol Serv, Leicester, Leics, England
[3] Natl Ctr Phthisiol, Bishkek, Kyrgyzstan
[4] Kyrgyz Indian Mt Biomed Res Ctr, Bishkek, Kyrgyzstan
[5] Glenfield Hosp, Dept Resp Med, Leicester, Leics, England
基金
英国生物技术与生命科学研究理事会;
关键词
RESUSCITATION-PROMOTING FACTORS; PULMONARY TUBERCULOSIS; ANTITUBERCULOSIS TREATMENT; SOLID CULTURE; IN-VIVO; GROWTH; CHEMOTHERAPY; MOXIFLOXACIN; BACILLI; RELAPSE;
D O I
10.1128/AAC.01380-15
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Tuberculous sputum contains multiple Mycobacterium tuberculosis populations with different requirements for isolation in vitro. These include cells that form colonies on solid media (plateable M. tuberculosis), cells requiring standard liquid medium for growth (nonplateable M. tuberculosis), and cells requiring supplementation of liquid medium with culture supernatant (SN) for growth (SN-dependent M. tuberculosis). Here, we describe protocols for the cryopreservation and direct assessment of antimicrobial tolerance of these M. tuberculosis populations within sputum. Our results show that first-line drugs achieved only modest bactericidal effects on all three populations over 7 days (1 to 2.5 log(10) reductions), and SN-dependent M. tuberculosis was more tolerant to streptomycin and isoniazid than the plateable and nonplateable M. tuberculosis strains. Susceptibility of plateable M. tuberculosis to bactericidal drugs was significantly increased after passage in vitro; thus, tolerance observed in the sputum samples from the population groups was likely associated with mycobacterial adaptation to the host environment at some time prior to expectoration. Our findings support the use of a simple ex vivo system for testing drug efficacies against mycobacteria that have phenotypically adapted during tuberculosis infection.
引用
收藏
页码:2476 / 2483
页数:8
相关论文
共 50 条
  • [1] Targeting Phenotypically Tolerant Mycobacterium tuberculosis
    Gold, Ben
    Nathan, Carl
    MICROBIOLOGY SPECTRUM, 2017, 5 (01):
  • [2] Mycobacterium tuberculosis resistance pattern against first-line drugs in patients from urban area
    Cucunawangsih
    Wiwing, Veronica
    Widysanto, Allen
    Lugito, Nata Pratama Hardjo
    INTERNATIONAL JOURNAL OF MYCOBACTERIOLOGY, 2015, 4 (04) : 302 - 305
  • [3] Blood agar for susceptibility testing of Mycobacterium tuberculosis against first-line drugs
    Coban, AY
    Cihan, CC
    Bilgin, K
    Uzun, M
    Akgunes, A
    Cetinkaya, E
    Durupinar, B
    INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE, 2006, 10 (04) : 450 - 453
  • [4] Mutations and insights into the molecular mechanisms of resistance of Mycobacterium tuberculosis to first-line drugs
    Rossini, Nicolas de Oliveira
    Dias, Marcio Vinicius Bertacine
    GENETICS AND MOLECULAR BIOLOGY, 2023, 46 (01)
  • [5] Resistance of Mycobacterium tuberculosis to four first-line anti-tuberculosis drugs in Japan, 1997
    Abe, C
    Hirano, K
    Wada, M
    Aoyagi, T
    INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE, 2001, 5 (01) : 46 - 52
  • [6] Molecular Basis of Resistance to First-Line Drugs of Mycobacterium tuberculosis/canettii Strains in Greece
    Florou, Zoi
    Mavroidi, Aggeliki
    Vatidis, George
    Daniil, Zoi
    Gourgoulianis, Konstantinos
    Petinaki, Efi
    MICROBIAL DRUG RESISTANCE, 2021, 27 (10) : 1389 - 1396
  • [7] Vitamin C Potentiates the Killing of Mycobacterium tuberculosis by the First-Line Tuberculosis Drugs Isoniazid and Rifampin in Mice
    Vilcheze, Catherine
    Kim, John
    Jacobs, William R., Jr.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2018, 62 (03)
  • [8] The Mycobacterium tuberculosis Uganda II family and resistance to first-line anti-tuberculosis drugs in Uganda
    Ezati, Nicholas
    Lukoye, Deus
    Wampande, Eddie M.
    Musisi, Kenneth
    Kasule, George W.
    Cobelens, Frank G. J.
    Kateete, David P.
    Joloba, Moses L.
    BMC INFECTIOUS DISEASES, 2014, 14
  • [9] Utility of Phenotypic and Genotypic Testing in the Study of Mycobacterium tuberculosis Resistance to First-Line Anti-Tuberculosis drugs
    Alba Alvarez, Luz Maria
    Garcia Garcia, Jose Maria
    Dolores Perez Hernandez, M.
    Martinez Gonzalez, Susana
    Palacios Gutierrez, Juan Jose
    ARCHIVOS DE BRONCONEUMOLOGIA, 2017, 53 (04): : 192 - 198
  • [10] The Mycobacterium tuberculosisUganda II family and resistance to first-line anti-tuberculosis drugs in Uganda
    Nicholas Ezati
    Deus Lukoye
    Eddie M Wampande
    Kenneth Musisi
    George W Kasule
    Frank GJ Cobelens
    David P Kateete
    Moses L Joloba
    BMC Infectious Diseases, 14